Impact of Drug Manipulation on Seizure Freedom in Adults with Uncontrolled Epilepsy: A Prospective Controlled Study in Rural China

被引:10
|
作者
Hao, Xiaoting [1 ]
Chen, Ziyi [2 ]
Yan, Bo [1 ]
Kwan, Patrick [3 ,4 ,5 ,6 ]
Zhou, Dong [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610000, Sichuan, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China
[3] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia
[4] Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia
[5] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[6] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic 3050, Australia
基金
中国国家自然科学基金;
关键词
CONVULSIVE EPILEPSY; REFRACTORY EPILEPSY; ANTIEPILEPTIC DRUG; RESISTANT EPILEPSY; ILAE/IBE/WHO; REDUCTION; DEATH;
D O I
10.1007/s40263-016-0397-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction It has been suggested that uncontrolled epilepsy might not necessarily equate to drug resistance when antiepileptic drugs (AEDs) are used at relatively low doses, a practice frequently observed in rural areas of China. Objective To assess the clinical benefits of further drug manipulation in this situation, we prospectively followed up the outcomes of patients with uncontrolled epilepsy while taking relatively low doses of AEDs. Methods The study included patients aged 16 years and older with uncontrolled epilepsy and who were receiving at least one AED at a dosage below 50% of the World Health Organization (WHO) defined daily dose (DDD) (50% DDD) (Group 1). Patients with drug-resistant epilepsy were included for comparison (Group 2). Both groups were followed- up for at least 2 years. Seizure outcomes after further drug manipulations were recorded at the last follow-up. Results A total of 197 patients (55.3% male) were included in Group 1 and 32 (46.9% male) in Group 2; their mean duration of follow-up was 28.85 +/- 1.90 and 30.91 +/- 2.04 months, respectively. At the last follow-up, 16.8% (33/197) of patients in Group 1 had become seizure-free compared with none in Group 2 (p < 0.001). Seventeen of 93 (18.3%) patients in Group 1 became seizure free after increasing the dosage of baseline AED(s) alone. Only 5.5% (3/55) of patients who had failed to respond to an AED at >= 50% DDD at baseline became seizure free compared with 21.1% (30/142) who did not have such a history (p = 0.001). The number of AEDs taken at a dosage below 50% DDD at baseline was not associated with seizure outcome. Conclusions Uncontrolled epilepsy could become controlled in a substantial proportion of patients by dose increase alone, particularly if there is no history of drug failure at >= 50% DDD.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 50 条
  • [31] Early assessment of responsive neurostimulation for drug-resistant epilepsy in China: A multicenter, self-controlled study
    Yang Yanfeng
    Wei Penghu
    Shi Jianwei
    Mao Ying
    Zhang Jianmin
    Lei Ding
    Yang Zhiquan
    Song Shiwei
    Qian Ruobing
    Li Wenling
    Shan Yongzhi
    Zhao Guoguang
    中华医学杂志英文版, 2025, 138 (04)
  • [32] A nationwide study of the impact of social quality factors on life satisfaction among older adults in rural China
    Xia, Yanfang
    Wang, Guoyong
    Yang, Fan
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [33] Clinical impact of therapeutic drug monitoring for newer anti-seizure medications in patients with epilepsy: A real-world observation study
    Lim, Siew-Na
    Wu, Tony
    Chang, Chun-Wei
    Tseng, Wei-En Johnny
    Cheng, Mei-Yun
    Hsieh, Hsiang-Yao
    Lee, Chih-Hong
    Lin, Wey-Ran
    Liu, Chun-Jing
    Chen, Po-Ru
    Lin, Chia-Ni
    BIOMEDICAL JOURNAL, 2024, 47 (05)
  • [34] Uncontrolled seizures after discontinuation of antiepileptic drug treatment in seizure-free patients with childhood-onset epilepsy:: A long-term population-based study
    Schmidt, D.
    Sillanpää, M.
    EPILEPSIA, 2006, 47 : 2 - 2
  • [35] The impact of drug-resistant epilepsy in an outpatient clinic of a tertiary hospital. A prospective study based on clinical practice
    Gravalos, M.
    Mayol, J.
    Fonseca, E.
    Quintana, M.
    Lopez-Maza, S.
    Campos-Fernandez, D.
    Abraira, L.
    Santamarina, E.
    Toledo, M.
    EPILEPSIA, 2024, 65 : 80 - 81
  • [36] Seizure outcome after hippocampal deep brain stimulation in patients with refractory temporal lobe epilepsy: A prospective, controlled, randomized, double-blind study
    Cukiert, Arthur
    Cukiert, Cristine Mella
    Burattini, Jose Augusto
    Mariani, Pedro Paulo
    Bezerra, Daniela Fontes
    EPILEPSIA, 2017, 58 (10) : 1728 - 1733
  • [37] EFFECTS OF EPILEPSY SURGERY ON SLEEP MACROSTRUCTURE AND MICROSTRUCTURE IN PATIENTS WITH DRUG-RESISTANT TEMPORAL LOBE EPILEPSY DUE TO HIPPOCAMPAL SCLEROSIS: A PROSPECTIVE CONTROLLED POLYSOMNOGRAPHIC STUDY
    Romigi, A.
    D'Aniello, A.
    Caccamo, M.
    Testa, F.
    Cappellano, S.
    Vitrani, G.
    Grammaldo, L.
    De Risi, M.
    Esposito, V.
    Centonze, D.
    Di Gennaro, G.
    SLEEP MEDICINE, 2022, 100 : S179 - S179
  • [38] QUality of life and Economic evaluation after neuroSTimulation for Epilepsy (QUESTE) in adolescents and adults with drug-resistant epilepsy: protocol for a multicentre, prospective observational cohort study in The Netherlands
    Smeets, Jacco J. A. S.
    Rijkers, Kim
    Ackermans, Linda
    Schijns, Olaf
    van Mastrigt, Ghislaine A. P. G.
    Rouhl, Rob
    Wagner, G. Louis
    van Kuijk, Sander
    Nelissen, Jeske
    van Straaten, Ilse E. C. W.
    Kho, Kuan
    Snoeijen-Schouwenaars, Francesca
    Meppelink, Anne-Marthe
    Klinkenberg, Sylvia
    Majoie, H. J. M.
    BMJ OPEN, 2023, 13 (06):
  • [39] Impact of number of anti-seizure medications on long-term health-related quality of life in children with epilepsy: A prospective cohort study
    Nouri, Maryam Nabavi
    Puka, Klajdi
    Palmar, Katie
    Speechley, Kathy N.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2022, 99 : 120 - 126
  • [40] Rapid versus slow withdrawal of antiepileptic monotherapy in 2‑year seizure‑free adult patients with epilepsy (RASLOW) study: a pragmatic multicenter, prospective, randomized, and controlled study—letter to the editor
    Baikuntha Panigrahi
    Manjari Tripathi
    Neurological Sciences, 2022, 43 : 6991 - 6992